✦ LIBER ✦

A Phase I Dose-Escalation Trial of High-Dose Melphalan with Palifermin for Cytoprotection Followed by Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Normal Renal Function

✍ Scribed by Abidi, Muneer H.; Agarwal, Rishi; Tageja, Nishant; Ayash, Lois; Deol, Abhinav; Al-Kadhimi, Zaid; Abrams, Judith; Cronin, Simon; Ventimiglia, Marie; Lum, Lawrence; Ratanatharathorn, Voravit; Zonder, Jeffrey; Uberti, Joseph

Book ID: 122565372
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 152 KB
Volume: 19
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2012.08.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Timing of High Dose Melphalan (HDM) and

Timing of High Dose Melphalan (HDM) and Outcomes for Autologous Stem Cell Transplantation (ASCT) in Patients With Multiple Myeloma (MM)

✍ A. Mahindra; B. Bolwell; L. Rybicki; R. Sobecks; B. Pohlman; S. Andresen; M. Ear 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 75 KB

A phase I dose escalation study of high-

A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies

✍ Demirer, T; lhan, O; Mandel, N M; Arat, M; Günel, N; Çelebi, H; Üstün, C; Akan, 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB

Phase I/II study of tandem high-dose che

Phase I/II study of tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation for advanced multiple myeloma

✍ Kazutaka Sunami; Katsuji Shinagawa; Morio Sawamura; Akira Sakai; Yoshio Saburi; 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 277 KB

Phase II Trial of Busulfan-Based Tandem

Phase II Trial of Busulfan-Based Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed By Reduced Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma

✍ Chen, Yi-Bin; Li, Shuli; Del Rio, Candice; Driscoll, Jessica; Sadrzadeh, Hossein 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Bortezomib salvage followed by a Phase I

Bortezomib salvage followed by a Phase I/II study of bortezomib plus high-dose melphalan and tandem autologous transplantation for patients with primary resistant myeloma

✍ Taiga Nishihori; Todd J. Alekshun; Kenneth Shain; Daniel M. Sullivan; Rachid Baz 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

Complete remission after myeloablation w

Complete remission after myeloablation with bone-seeking 186Re-HEDP and high-dose melphalan followed by autologous stem cell transplantation in a patient with chemorefractory multiple myeloma

✍ Wiesmann, A; Einsele, H; Kanz, L; Dohmen, B M 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 87 KB